- Endocrinology and Metabolism Training Program awarded by National Institutes of Health 2024 - 2029
- Case, Laura E., Rabi Hanna, Donald P. Frush, Vidya Krishnamurthy, Stephanie DeArmey, Joanne Mackey, Anne Boney, et al. “Fractures in children with Pompe disease: a potential long-term complication.” Pediatr Radiol 37, no. 5 (May 2007): 437–45. https://doi.org/10.1007/s00247-007-0428-y.
- Weber, Thomas J., Shiguang Liu, Olafur S. Indridason, and L Darryl Quarles. “Serum FGF23 levels in normal and disordered phosphorus homeostasis.” J Bone Miner Res 18, no. 7 (July 2003): 1227–34. https://doi.org/10.1359/jbmr.2003.18.7.1227.
- Weber, T. J., and M. K. Drezner. “Effect of alendronate on bone mineral density in male idiopathic osteoporosis.” Metabolism 50, no. 8 (August 2001): 912–15. https://doi.org/10.1053/meta.2001.24925.
- De Beur, Suzanne Jan, Paul D. Miller, Thomas J. Weber, Munro Peacock, Karl L. Insogna, Rajiv Kumar, Frank Rauch, et al. “Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome.” In JOURNAL OF BONE AND MINERAL RESEARCH, 33:50–50. WILEY, 2018.
- De Beur, Suzanne Jan, Paul D. Miller, Thomas J. Weber, Munro Peacock, Mary D. Ruppe, Karl Insogna, Diana Luca, Christina Theodore-Oklota, Javier San Martin, and Thomas Carpenter. “Effects of Burosumab (KRN23), a Human Monoclonal Antibody to FGF23, in Patients with Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS).” In JOURNAL OF BONE AND MINERAL RESEARCH, 32:S280–S280. WILEY, 2017.
- Weber, T. J., E. K. Sawyer, S. Moseley, T. OdrIjin, and P. S. Kishnani. “FRACTURE AND SURGICAL BURDEN IN PEDIATRIC AND ADULT PATIENTS WITH HYPOPHOSPHATASIA: RESULTS FROM PATIENT-REPORTED OUTCOME SURVEYS.” In OSTEOPOROSIS INTERNATIONAL, 26:S90–91. SPRINGER LONDON LTD, 2015.
Patient Reviews
Patient comments are gathered from our Press Ganey Patient Survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy